{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:48:54Z","timestamp":1760028534039},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombol"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/bf01061991","type":"journal-article","created":{"date-parts":[[2005,1,30]],"date-time":"2005-01-30T03:44:27Z","timestamp":1107056667000},"page":"17-25","source":"Crossref","is-referenced-by-count":23,"title":["Bleeding complications to long-term oral anticoagulant therapy"],"prefix":"10.1007","volume":"1","author":[{"given":"Annette Lemche","family":"Gull\ufffdv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitte Gade","family":"Koefoed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Palle","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1001\/archinte.1991.00400100010002","volume":"151","author":"JE Dalen","year":"1991","unstructured":"Dalen JE. Atrial fibrillation and embolic stroke.Arch Intern Med 1991;151:1922?1924.","journal-title":"Arch Intern Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJM199106273242606","volume":"324","author":"J Hirsh","year":"1991","unstructured":"Hirsh J. Oral anticoagulant drugs.N Engl J Med 1991;324:1865?1875.","journal-title":"N Engl J Med"},{"key":"CR3","first-page":"700","volume":"154","author":"M M\u00f8ller","year":"1992","unstructured":"M\u00f8ller M, Pindborg T, Sand\u00f8e E, Simonsen EH, Thomsen PEB. Kardiale arytmier. Diagnostik og behandling.Ugeskr L\u00e6ger 1992;154:700?714.","journal-title":"Ugeskr L\u00e6ger"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.410160505","volume":"16","author":"AR Wintzen","year":"1984","unstructured":"Wintzen AR, de Jonge H, Loeliger EA, Bots GTAM. The risk of intracerebral haemorrhage during oral anticoagulant treatment: A population study.Ann Neurol 1984;16:553?558.","journal-title":"Ann Neurol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0002-9343(88)90105-2","volume":"84","author":"CM Wilcox","year":"1988","unstructured":"Wilcox CM, Truss CD. Gastrointestinal bleeding in patients receiving long-term anticoagulant therapy.Am J Med 1988;84:683?690.","journal-title":"Am J Med"},{"issue":"Suppl","key":"CR6","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1378\/chest.95.2_Supplement.26S","volume":"95","author":"MN Levine","year":"1989","unstructured":"Levine MN, Raskob G, Hirsh J. Haemorrhagic complications of long-term anticoagulant therapy.Chest 1989;95(Suppl):26S-36S.","journal-title":"Chest"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0002-9343(89)80689-8","volume":"87","author":"CS Landefeld","year":"1989","unstructured":"Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy.Am J Med 1989;87:144?152.","journal-title":"Am J Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0002-9343(89)80690-4","volume":"87","author":"CS Landefeld","year":"1989","unstructured":"Landefeld CS, Rosenblatt MW, Goldman L. Bleeding in out-patients treated with warfarin: Relation to the prothrombin time and important remediable lesions.Am J Med 1989;87:153?159.","journal-title":"Am J Med"},{"key":"CR9","first-page":"17","volume":"152","author":"O May","year":"1990","unstructured":"May O, Garne E, Mickley H. Komplikationer til langtidsbehandling med vitamin K-antagonister.Ugeskr L\u00e6ger 1990;152:17?20.","journal-title":"Ugeskr L\u00e6ger"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2796.1991.tb00358.x","volume":"229","author":"J Launbjerg","year":"1991","unstructured":"Launbjerg J, Egeblad H, Heaf J, Nielsen NH, Fugleholm AM, Ladefoged K. Bleeding complications to oral anticoagulant therapy.J Intern Med 1991;229:352?355.","journal-title":"J Intern Med"},{"key":"CR11","first-page":"81","volume":"687","author":"WHO Expert Committee on Biological Standardization","year":"1983","unstructured":"WHO Expert Committee on Biological Standardization. 33 Report WHO Tech. Rep. Ser. 1983;687:81?105.","journal-title":"33 Report WHO Tech. Rep. Ser."},{"key":"CR12","first-page":"38","volume":"30","author":"J Jespersen","year":"1988","unstructured":"Jespersen J. Den standardiserede protrombintidsbestem-melse?International Normalized Ratio (INR) og dens tera-peutiske intervaller.Ugeskr L\u00e6ger 1988;30:38?41.","journal-title":"Ugeskr L\u00e6ger"},{"key":"CR13","first-page":"147","volume":"3\/4","author":"AMHP Besselaar van den","year":"1991","unstructured":"van den Besselaar AMHP. The significance of the International Normalized Ratio (INR) for oral anticoagulant therapy.JIFCC. 1991;3\/4:147?153.","journal-title":"JIFCC."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","volume":"1","author":"P Petersen","year":"1989","unstructured":"Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study.Lancet 1989;1:175?179.","journal-title":"Lancet"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJM199007193230302","volume":"323","author":"P Smith","year":"1990","unstructured":"Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction.N Engl J Med 1990;323:147?152.","journal-title":"N Engl J Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","volume":"323","author":"The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators","year":"1990","unstructured":"The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation.N Engl J Med 1990;323:1505?1511.","journal-title":"N Engl J Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","volume":"84","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1991","unstructured":"Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study. Final results.Circulation 1991;84:527?539.","journal-title":"Circulation"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0735-1097(91)90585-W","volume":"18","author":"SJ Connolly","year":"1991","unstructured":"Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) study.J Am Coll Cardiol 1991;18:149?155.","journal-title":"J Am Coll Cardiol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","volume":"12","author":"MD Ezekowitz","year":"1992","unstructured":"Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation.N Engl J Med 1992;12:1406?1412.","journal-title":"N Engl J Med"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","volume":"342","author":"EAFT Study Group","year":"1993","unstructured":"EAFT Study Group. European atrial fibrillation trial: Secondary prevention of vascular events in patients with non-rheumatic atrial fibrillation and a recent transient ischemic attack or minor ischemic stroke.Lancet 1993;342:1255?1261.","journal-title":"Lancet"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","volume":"329","author":"AGG Turpie","year":"1993","unstructured":"Turpie AGG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.N Engl J Med 1993;329:524?529.","journal-title":"N Engl J Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1001\/archinte.1991.00400100038006","volume":"151","author":"M Kutner","year":"1991","unstructured":"Kutner M, Nixon G, Silverstone F. Physicians' attitude toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.Arch Intern Med 1991;151:1950?1953.","journal-title":"Arch Intern Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/0140-6736(93)90950-L","volume":"341","author":"JJ Caro","year":"1993","unstructured":"Caro JJ, Groome PA, Flegel KM. Atrial fibrillation and anti-coagulation: From randomised trials to practice.Lancet 1993;341:1381?1384.","journal-title":"Lancet"},{"issue":"Suppl","key":"CR24","first-page":"5S","volume":"95","author":"J Hirsh","year":"1989","unstructured":"Hirsh J, Poller L, Deykin D, et al. Optimal therapeutic range for oral anticoagulants.Chest 1989;95(Suppl):5S-11S.","journal-title":"Chest"},{"issue":"Suppl","key":"CR25","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1378\/chest.95.2_Supplement.37S","volume":"95","author":"TM Hyers","year":"1989","unstructured":"Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease.Chest 1989;95(Suppl):37S-51S.","journal-title":"Chest"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJM199311043291902","volume":"329","author":"R Hull","year":"1993","unstructured":"Hull R, Raskob G, Pineo G, et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.N Engl J Med 1993;329:1370?1376.","journal-title":"N Engl J Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1001\/archinte.1984.04400010074014","volume":"144","author":"AM Errichetti","year":"1984","unstructured":"Errichetti AM, Holden A, Ansell J. Management of oral anticoagulant therapy. Experience with an anticoagulation clinic.Arch Intern Med 1984;144:1966?1968.","journal-title":"Arch Intern Med"},{"issue":"Suppl","key":"CR28","first-page":"S57","volume":"68","author":"M Dunn","year":"1992","unstructured":"Dunn M, Blackburn T. Anticoagulant treatment of atrial fibrillation in the elderly.Postgrad Med J 1992;68(Suppl): S57-S60.","journal-title":"Postgrad Med J"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archinte.1988.00380080037012","volume":"148","author":"JH Gurwitz","year":"1988","unstructured":"Gurwitz JH, Goldberg RJ, Holden A, et al. Age-related risks of long-term oral anticoagulant therapy.Arch Intern Med 1988;148:1733?1736.","journal-title":"Arch Intern Med"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/s-0038-1646892","volume":"62","author":"S Kumar","year":"1989","unstructured":"Kumar S, Haigh JRM, Rhodes LE, et al. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy.Thrombo Haemost 1989;62:729?732.","journal-title":"Thrombo Haemost"},{"key":"CR31","first-page":"1616","volume":"10","author":"AL Gull\u00f8v","year":"1993","unstructured":"Gull\u00f8v AL, Koefoed BG, Petersen P. Atrial fibrillation, aspirin and anticoagulant therapy (AFASAK 2) (abstract).Stroke 1993;10:1616.","journal-title":"Stroke"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01061991.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01061991\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01061991","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T13:51:10Z","timestamp":1586094670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01061991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994]]}},"alternative-id":["BF01061991"],"URL":"https:\/\/doi.org\/10.1007\/bf01061991","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994]]}}}